BiotechTube
Home/Novartis/Charlotte Pamer-Wieser, Ph.D.
CP

Charlotte Pamer-Wieser, Ph.D.

Corporate Secretary

Novartis

Therapeutic Areas

OncologyNeuroscienceImmunologyCardiovascularRenalMetabolic

Novartis Pipeline

DrugIndicationPhase
Cosentyx®Pediatric Hidradenitis Suppurativa (12+)Approved
Pan-mutant-selective PI3Kα inhibitorBreast CancerAcquisition

Leadership Team at Novartis

GC
Giovanni Caforio, M.D.
Board Chair
SM
Simon Moroney, D.Phil.
Vice-Chair
NC
Nancy C. Andrews, M.D., Ph.D.
Board Member
TB
Ton Buechner
Board Member
PB
Patrice Bula
Lead Independent Director
E(
Elizabeth (Liz) Doherty
Board Member
BH
Bridgette Heller
Board Member
FV
Frans van Houten
Board Member
EM
Elizabeth McNally, M.D., Ph.D.
Board Member
AD
Ana de Pro Gonzalo
Board Member
View full Novartis profile